Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




FDA Safety Changes: Antidepressants, Plasma-Lyte 148, Tyzeka
Link ID 14579
Title FDA Safety Changes: Antidepressants, Plasma-Lyte 148, Tyzeka
Url http://www.medscape.com/viewarticle/590191?src=rss
Description The FDA has approved revisions to the safety labeling for various selective serotonin and serotonin-norepinephrine reuptake inhibitors; multiple electrolytes injection, type 1; and telbivudine. Medscape Medical News
Category Articles > Family Medicine
Keywords
Date Mar 27, 2009
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 5.00 (out of 5)
Number of ratings: 1 Votes
Visitor Rating

 Other links at Articles > Family Medicine
1. Compressive Cryotherapy Tops Solo Cryotherapy After ACL Reconstruction
  Compression cryotherapy after ACL reconstruction results in good short-term pain relief and a greater likelihood of independence from narcotic use compared with cryotherapy alone. Medscape Medical News
Category:   Articles > Family Medicine


2. Screening at 2 Months Identifies Most Women With Postpartum Depression
  Using a well-child visit to screen for postpartum depression 2 months after delivery will catch the majority of women likely to develop the condition within the first 6 postpartum months. Medscape Medical News
Category:   Articles > Family Medicine


3. NKF 2009: Hepatitis C Virus Coinfection Accelerates Chronic Kidney Disease
  In a multivariate analysis, only hepatitis C virus status and age predicted death or end-stage renal disease. Medscape Medical News
Category:   Articles > Family Medicine


4. FDA Approves Longer Valganciclovir CMV Prophylaxis for Kidney Transplant Patients
  The FDA has approved an extended prophylactic dosing interval for valganciclovir HCl tablets in adult kidney transplant patients at high risk for cytomegalovirus disease. Medscape Medical News
Category:   Articles > Family Medicine


5. Advances In the Systemic Therapy of Malignant Pleural Mesothelioma
  Rates of malignant pleural mesothelioma are expected to rise, and new research has highlighted the best means to use systemic therapy to improve the course of this disease. The current article reviews this research and focuses on future directions for the care of patients with malignant pleural mesothelioma. Nature Clinical Practice Oncology
Category:   Articles > Family Medicine




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS